GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Days Payable

Hard to Treat Diseases (Hard to Treat Diseases) Days Payable : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Days Payable?

Hard to Treat Diseases's average Accounts Payable for the three months ended in . 20 was $0.00 Mil. Hard to Treat Diseases's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Hard to Treat Diseases's Days Payable or its related term are showing as below:

HTDS's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

Hard to Treat Diseases's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00). stayed the same


Hard to Treat Diseases Days Payable Historical Data

The historical data trend for Hard to Treat Diseases's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Days Payable Chart

Hard to Treat Diseases Annual Data
Trend
Days Payable

Hard to Treat Diseases Quarterly Data
Days Payable

Competitive Comparison of Hard to Treat Diseases's Days Payable

For the Biotechnology subindustry, Hard to Treat Diseases's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hard to Treat Diseases's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Days Payable distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Days Payable falls into.



Hard to Treat Diseases Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hard to Treat Diseases's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Hard to Treat Diseases's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 4
=0 / *365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hard to Treat Diseases Days Payable Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines